Press release
Global Controlled Release Drug Delivery Market Projected to Grow at 12.8% CAGR, Reaching $117.24 Billion by 2029
Controlled Release Drug Delivery Market
What Will the Controlled Release Drug Delivery Industry Market Size Be by 2025?
The size of the controlled release drug delivery market has seen significant expansion lately. The market is projected to inflate from $65.44 billion in 2024, and escalate to a value of $72.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.5%. This growth over the history can be traced to groundbreaking drug delivery systems, earlier polymer-based formulations, the adoption of microencapsulation techniques, the rise of transdermal delivery, regulatory consent and standardization.
What's the Long-Term Growth Forecast for the Controlled Release Drug Delivery Market Size Through 2029?
Anticipated to experience swift expansion in the coming years, the controlled release drug delivery market is projected to reach "$ 117.24 billion by 2029 with a compound annual growth rate (CAGR) of 12.8%. Factors contributing to this predicted growth during the forecast period include the transition towards customised medicine, patient-focused technological advancements, growth of biological and biosimilars sector, market development in emerging regions, and progress in the field of polymer science. The forecast period is also expected to witness major trends like the use of biodegradable and biocompatible materials, developments in nanotechnology, personalised medicine and targeted therapies, breakthroughs in implantable devices, and innovation in encapsulation techniques.
View the full report here:
https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report
What Are the Key Growth Drivers Fueling the Controlled Release Drug Delivery Market Expansion?
An uptick in chronic diseases is anticipated to boost the expansion of the controlled release drug delivery market. Chronic conditions, otherwise referred to as noncommunicable diseases, encompass health issues like heart disease, cancer, and diabetes. These diseases last for more than a year and necessitate ongoing medical attention, restrict daily activities, or both. The treatment of chronic diseases heavily relies on controlled-release drug delivery. Patients suffering from chronic diseases that require long-term treatment or those living in regions with limited medical resources and healthcare access, it's imperative to have drug delivery methods that support extended medication release. For example, according to a World Health Organization (WHO) report from September 2022, a health-focused organization based in Switzerland, 41 million people annually succumb to chronic diseases, contributing to 74% of all deaths globally. 17 million individuals die from chronic diseases before reaching 70 years of age, and 77% of chronic disease-related deaths occur in lower to middle-income countries. These statistics are projected to escalate in the future. In light of this, the climbing rates of chronic diseases are stimulating growth in the controlled release drug delivery market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp
What Trends Will Shape the Controlled Release Drug Delivery Market Through 2029 and Beyond?
Advancements in technology are emerging as a significant trend in the controlled-release drug delivery market. Many leading entities in the controlled-release drug delivery market are integrating these latest technologies to stay competitive. For example, in March 2022, Evonik Industries AG, a pharmaceutical firm based in Germany, introduced UDRATEC SoluFlow. This latest microparticle innovation is devised to enhance the solubility of key medical components in oral medication formulations. Its emulsion-based process method surpasses solubility obstacles that traditional manufacturing techniques fail to conquer. Adding to Evonik Health Care's variety of oral drug delivery system solutions, EUDRATEC SoluFlow is accompanied by oral excipients like EUDRAGIT functional polymers, ready-to-fill practical capsules like EUDRACAPTM, and other mechanisms and services aimed at bettering medication performance.
How Is the Controlled Release Drug Delivery Market Segmented?
The controlled release drug delivery market covered in this report is segmented -
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp
Which Companies Are Leading the Charge in Controlled Release Drug Delivery Market Innovation?
Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.
Which Regions Are Leading the Global Controlled Release Drug Delivery Market in Revenue?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Controlled Release Drug Delivery Market Projected to Grow at 12.8% CAGR, Reaching $117.24 Billion by 2029 here
News-ID: 4180387 • Views: …
More Releases from The Business Research Company
Emerging Trends to Reshape the Organic Pharmaceutical Excipients Market: Label-F …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Organic Pharmaceutical Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, there has been significant growth in the market size of organic pharmaceutical excipients. It is predicted that the market will expand from its $11.25 billion valuation in 2024 to…
Non Hodgkin Lymphoma (NHL) Market Landscape to 2034: Key Forces Shaping the Next …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Non Hodgkin Lymphoma (NHL) Market Size By 2025?
The market for non-hodgkin lymphoma (NHL) has seen significant growth in recent times. An increase from $10.11 billion in 2024 to $10.86 billion in 2025 is projected, which represents a compound annual growth rate (CAGR) of 7.5%.…
Asthma Drugs Market Growth Accelerates: Strategic Forecast Predicts $31.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Asthma Drugs Industry Market Size Be by 2025?
In the past few years, the longevity of the asthma medications market has been systematically expanding. This market, which worth $23.96 billion in 2024, will surge to $24.93 billion in 2025, registering a compound annual growth rate (CAGR)…
Soaring Demand Set to Propel Multiple Myeloma Drugs Market to $29.44 Billion by …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Multiple Myeloma Drugs Market Through 2025?
The market for multiple myeloma drugs has seen significant growth in recent times. The market is projected to increase from $21.84 billion in 2024 to $23.03 billion in 2025, experiencing a compound annual growth rate (CAGR)…
More Releases for Delivery
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences…
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market…
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period."
Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
Telemedicine Market Report 2022 by Mode of Delivery, End User, Region-Cloud base …
The Telemedicine market will reach US$ 387.7 Mn by 2028 - Persistence Market Research (PMR), a well-known name in market research.
The current scenario is such that people and healthcare professionals are increasingly preferring virtual consulting due its low costs and effective treatment. This scenario is, by all means, favoring the Telemedicine market growth.
The forecast period (2022-2028) will see North America scale greater heights in the Telemedicine market. This is basically…
